Insect-selective carbamate insecticide sparing mammals
This technology consists of a new class of carbamate insecticides designed to kill mosquitoes while remaining non-toxic to humans. It works by targeting a specific enzyme in the insect's nervous system known as acetylcholinesterase, using a molecular structure that selectively binds to the insect version of the enzyme but ignores the human version. These chemical compounds are particularly effective for treating surfaces where human contact is frequent, offering a safer alternative to traditional broad-spectrum pesticides.
What you could build
A specialized chemical coating for mosquito nets and indoor wall sprays designed for use in malaria-prone regions or high-density residential areas.
Who in Virginia should care
Virginia-based chemical manufacturers or global health NGOs with a presence in the DC-Northern Virginia corridor would find this relevant for vector control programs.
Readiness: Lab validated
Concept — described but not yet demonstrated. Lab validated — supported by experimental results in the patent. Prototype likely — the text describes a built, working embodiment.
Readiness is inferred from the patent text, not from a lab visit.
The record
- Inventors
- Paul Carlier, Jeffrey Bloomquist, Sally Paulson, Eric Wong
- Granted
- December 31, 2013
- Status
- Granted patent
- Patent number
- 8618162
Ready to talk?
Virginia Tech Intellectual Properties handles licensing for this technology.
Prosim summaries are generated from public patent text and are not legal advice.